Hailey Bieber deal may already be priced into elf Beauty stock

elf Beauty (ELF) shares rallied as much as 30% after announcing the $1 billion acquisition of Hailey Bieber's skincare brand, Rhode, but analysts suggest the upside may already be priced in. Piper Sandler raised its price target to $109, but this still implies potential downside, and the consensus target is near $97, roughly 20% below current levels. Despite a strong Q4 and the strategic benefits of acquiring Rhode, elf Beauty refrained from offering future guidance, and its forward EV/EBITDA multiple of over 29x is elevated compared to its historical average, warranting caution for investors.

Analysis

elf Beauty Inc. (ELF) experienced a significant stock price surge, rallying as much as 30%, following the announcement of its $1.0 billion acquisition of Hailey Bieber's skincare and cosmetics brand, Rhode. This transaction is positioned to enhance elf's footprint in the premium beauty segment and broaden its appeal to younger demographics. However, analyst commentary, including from Piper Sandler, suggests the substantial market reaction may have fully incorporated the anticipated benefits. Piper Sandler's Korinne Wolfmeyer increased her price target on ELF to $109, by raising the EV/EBITDA multiple assumption from 16x to 21x, yet this revised target still implies a potential downside of over 5% from current trading levels, indicating the rally may have been excessive. Compounding this cautious outlook, elf Beauty's management abstained from providing future financial guidance post-acquisition, leaving investors reliant on external analysis. The broader Wall Street consensus reflects a similar sentiment, with a mean target price of approximately $97, indicating a potential downside of around 20% from current levels. Valuation metrics further support a cautious stance; ELF's forward EV/EBITDA multiple now exceeds 29x, a notable premium to its five-year average of less than 25x, suggesting the stock is not inexpensive. This valuation concern persists despite a reported strong fiscal fourth quarter where elf Beauty earned 78 cents per share, saw a 3.6% year-on-year increase in net sales, gained 190 basis points of market share in the US, and continued its international expansion, as stated by its chief executive.

Key Decisions for Investors

• Given the significant stock appreciation and analyst price targets indicating potential downside, investors should exercise caution with elf Beauty shares at their current valuation.
• The lack of forward guidance from management post-acquisition, coupled with a forward EV/EBITDA multiple exceeding 29x, suggests that much of the positive news from the Rhode deal may already be priced in.
• Investors might consider monitoring for further details on the financial integration of Rhode and observing if the stock consolidates to a more attractive valuation level before considering new or increased positions.